vimarsana.com

Latest Breaking News On - Insider activity at aurinia pharmaceuticals - Page 1 : vimarsana.com

Cantor Fitzgerald Comments on Aurinia Pharmaceuticals Inc s FY2024 Earnings (NASDAQ:AUPH)

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for shares of Aurinia Pharmaceuticals in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer forecasts that the biotechnology company will post earnings of ($0.39) per share for the year. The consensus […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 1 9%

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP)’s stock price rose 1.9% on Thursday . The company traded as high as $10.18 and last traded at $10.14. Approximately 1,109,122 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 3,016,769 shares. The stock had previously closed at $9.95. Analyst […]

Aurinia Pharmaceuticals (TSE:AUP) Stock Price Down 3 5%

Shares of Aurinia Pharmaceuticals Inc. (TSE:AUP – Get Rating) (NASDAQ:AUPH) fell 3.5% during mid-day trading on Tuesday . The stock traded as low as C$16.41 and last traded at C$16.76. 4,611,683 shares changed hands during mid-day trading, an increase of 1,906% from the average session volume of 229,895 shares. The stock had previously closed at […]

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives $12 33 Average PT from Brokerages

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has earned an average recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.